Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
for the SURPASS-4 Investigators
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
The drug resistance mechanism involves metabolic abnormalities (such as downregulation of deoxycytidine kinase (dCK), nucleoside transporter hENT1 deficiency), enhanced DNA repair (overexpression of ribonucleotide reductase ribonucleotide reductase catalytic subunit M1 (RRM1)/ribonucleotide reductase catalytic subunit M2 (RRM2), and tumor microenvironment remodeling (such as secretion of immunosuppressive factors by CAFs)
We will be clear and straightforward and provide you with some tips
Peptide legality varies significantly by location
US$ 21.08
US$ 22.58
US$ 27.47
US$ 28.24
US$ 23.90
US$ 20.86
